• Underlying Pathophysiology
    • Hypobaric hypoxia: ↓ barometric pressure at high altitude → ↓ partial pressure of inspired O2 (PiO2) → ↓ arterial O2 saturation (SaO2).
    • The primary insult is hypoxia. Illnesses result from failed or incomplete acclimatization.
  • Physiologic Acclimatization
    • Immediate (minutes to hours):
      • Hyperventilation: Hypoxia stimulates peripheral chemoreceptors → ↑ respiratory rate → respiratory alkalosis.
      • ↑ Sympathetic activity: Tachycardia, ↑ cardiac output.
    • Intermediate (days):
      • ↑ 2,3-BPG: Right-shifts the O2-hemoglobin dissociation curve, facilitating O2 unloading to tissues.
      • Renal compensation: ↑ HCO3⁻ excretion to correct respiratory alkalosis.
    • Long-term (weeks to months):
      • ↑ Erythropoietin (EPO): Secreted by kidneys in response to hypoxia → ↑ hematocrit and hemoglobin concentration.
  • Prophylaxis
    • Primary method: Gradual ascent (allows for acclimatization).
    • Pharmacologic: Acetazolamide.
      • Mechanism: Carbonic anhydrase inhibitor. Causes metabolic acidosis by promoting renal HCO3⁻ excretion. This acidosis offsets respiratory alkalosis and stimulates ventilation.
      • Started 24-48 hours before ascent.

Spectrum of High-Altitude Illnesses

  • Acute Mountain Sickness (AMS)
    • Pathophysiology: Mild cerebral edema. Hypoxia → cerebral vasodilation → ↑ capillary pressure → fluid leak.
    • Clinical Features: Occurs >6-12 hours after ascent.
      • Headache is the hallmark symptom.
      • PLUS ≥1 of the following: fatigue/weakness, dizziness, nausea/vomiting, anorexia, sleep disturbance.
    • Treatment:
      • Halt ascent. Descend if symptoms worsen.
      • Symptomatic Tx: NSAIDs (for headache), antiemetics.
      • Acetazolamide can be used for treatment as well as prophylaxis.
  • High-Altitude Cerebral Edema (HACE)
    • Pathophysiology: Severe, life-threatening progression of AMS. Worsening vasogenic cerebral edema.
    • Clinical Features:
      • AMS symptoms PLUS neurologic dysfunction.
      • Ataxia (key finding; difficulty with heel-to-toe walk).
      • Confusion, altered mental status, drowsiness, progressing to coma.
    • Treatment:
      • IMMEDIATE DESCENT is life-saving.
      • Dexamethasone: Potent anti-inflammatory, reduces vasogenic edema.
      • Supplemental O2.
  • High-Altitude Pulmonary Edema (HAPE)
    • Pathophysiology: Most lethal form. Non-cardiogenic pulmonary edema.
      • Hypoxia → uneven pulmonary vasoconstriction → ↑ pulmonary artery pressure → endothelial damage → alveolar fluid leakage.
    • Clinical Features: Typically develops 2-4 days after ascent.
    • Dyspnea at rest (most common early Sx).
      • Non-productive cough → pink, frothy sputum.
      • Rales/crackles on lung auscultation, tachypnea, tachycardia, low-grade fever.
    • Treatment:
      • IMMEDIATE DESCENT.
      • Supplemental O2.
      • Pharmacologic Tx to ↓ pulmonary artery pressure:
        • Nifedipine (calcium channel blocker).
        • Sildenafil/Tadalafil (phosphodiesterase-5 inhibitors).